Nitof is a nicotine replacement therapy patch developed by HeteroHealthcare Limited (HHCL) - part of the Hetero Group, one of India's largest and most trusted generic pharmaceutical manufacturers with over 35 years of clinical and research experience.
Nitof is a prescription-only nicotine replacement therapy patch designed for adults who are ready to quit smoking and want to do so with proper medical support. The patch works by delivering measured doses of nicotine transdermally - through the skin - over 24 hours, maintaining stable nicotine levels in the bloodstream and reducing the physical withdrawal that makes quitting so difficult.
What sets Nitof apart from other NRT products is the ecosystem it operates within. HHCL has built Nitof not as a standalone product to be purchased at a pharmacy and used without guidance, but as the medical foundation of a complete digital smoking cessation programme - one that includes assessment, doctor consultation, counselling, behavioural coaching, and continuous support.
Manufactured by HeteroHealthcare Limited.
Prescription-only - physician-guided dosage.
Continuous transdermal nicotine delivery - no action needed.
Nitof uses a transdermal patch system - a technology that provides slow, controlled release of nicotine through the skin. Worn once daily on a clean, dry area of skin (upper arm, back, or chest), the patch maintains nicotine levels consistently across 24 hours. Application sites should be rotated daily to minimise skin irritation. The patch is discreet, easy to use, and works passively - requiring no ongoing action from you throughout the day.
Nitof is never used in isolation within the HHCL programme. The patch is your medical foundation - but it’s built into a journey that includes a personalised assessment, physician guidance on dosage and duration, WhatsApp and call-based counselling, and behavioural coaching. All of it is designed to move you toward one outcome: a smoke-free life.
Smoking cessation treatment that combines NRT with structured support consistently delivers significantly better quit outcomes than NRT alone. HeteroHealthcare built Nitof with this evidence in mind.
Nitof comes in three strengths matched to your level of smoking. The step-down approach gradually reduces nicotine dependency - no sudden cut-off, no overwhelming withdrawal.
Heavy Smokers
10+ cigarettes/day
Start here for heavy smokers. Highest dose
Moderate Smokers
7–8 cigarettes/day
Step down from 21 mg or starting dose for moderate smokers
Light / Maintenance
3–4 cigarettes/day
Final stage before becoming completely nicotine-free
Heavy Smokers
10+ cigarettes/day
Start here for heavy smokers. Highest dose
Moderate Smokers
7–8 cigarettes/day
Step down from 21 mg or starting dose for moderate smokers
Light / Maintenance
3–4 cigarettes/day
Final stage before becoming completely nicotine-free
Step-Down Path: 21 mg → 14 mg → 7 mg → Nicotine-Free
Most people complete the full journey in 8–12 weeks. Your doctor will set the duration at each stage.
Rx Only: Nitof is a prescription medication. The dose and duration must be determined by a registered medical practitioner. Do not self-prescribe.
No guesswork. No being left with a patch and a leaflet. Here is every step, from the moment you decide to quit, all the way through to a smoke-free life.
Understand what smoking addiction is, what withdrawal feels like, and what to expect. Knowledge removes fear.
3 quick questions determine your dependence level - low, moderate, or high. This shapes your entire plan.
Connect with a trained counsellor who walks you through your result and next steps. A real person, not a chatbot.
A physician confirms your Nitof dose and creates your personalised step-down plan.
Start patch-based treatment with counselling, craving management, and behavioural coaching alongside it.
Every touchpoint is designed to move you closer to smoke-free - no gap, no drop-off, no guesswork.
Weekly check-ins with your counsellor to track progress and manage difficulties.
Craving-response strategies - evidence-based techniques for getting through a craving in real time.
Step-down monitoring - your response is tracked as you transition from 21→14→7 mg.
Relapse prevention planning - what to do if you slip, and how to get back on track.
Cravings don’t follow office hours. The Nitof support system is built to be there when you actually need it - not just available in theory.
Message when a craving hits. Real-time, practical strategies - not a generic leaflet. Available for craving management, habit strategy questions, and programme guidance.
Speak to a trained counsellor. Genuine conversation, not a scripted helpline. Especially recommended for high-dependence individuals and those who have relapsed before.
Identifying triggers. Rebuilding routines. Managing the habit layer of smoking. This is the support layer most quit programmes skip - and the one that makes the difference between quitting short-term and staying smoke-free long-term.
Message when a craving hits. Real-time, practical strategies - not a generic leaflet. Available for craving management, habit strategy questions, and programme guidance.
Speak to a trained counsellor. Genuine conversation, not a scripted helpline. Especially recommended for high-dependence individuals and those who have relapsed before.
Identifying triggers. Rebuilding routines. Managing the habit layer of smoking. This is the support layer most quit programmes skip - and the one that makes the difference between quitting short-term and staying smoke-free long-term.
Smoking is the leading preventable cause of death globally. Every cigarette you smoke contains over 7,000 chemicals - at least 70 of which are known carcinogens. The risks include:
Important: The damage is largely reversible once you quit. Recovery begins within hours of your last cigarette.
Most cravings last 3–5 minutes at peak intensity. If you can outlast that window, the craving passes - every time. Strategies that genuinely help:
Heart rate and blood pressure begin to drop toward normal levels.
Carbon monoxide clears from your blood. Oxygen levels normalise.
Circulation improves. Lung function increases by up to 30%. Physical activities feel easier.
Shortness of breath reduces significantly. Coughing and respiratory infections become less frequent. Taste and smell sharpen.
Risk of coronary heart disease drops by 50% compared to a smoker.
Stroke risk equals that of a non-smoker. Cancer risk of mouth, throat, and oesophagus drops by half.
Lung cancer risk falls to roughly half that of a continuing smoker. Cancers of kidney and pancreas also significantly reduced.
Risk of coronary heart disease now matches that of someone who never smoked.
© HeteroHealthcare Limited. All rights reserved. | heterohealthcare.com / nitof | For medical queries: consult your registered healthcare provider